scinapse is loading now...
Paula Amato
Oregon Health & Science University
42Publications
21H-index
2,192Citations
Publications 42
Newest
Published on May 2, 2019in Journal of Maternal-fetal & Neonatal Medicine 1.49
Emily K. Clennon (Oregon Health & Science University), Emmanuelle Paré (Oregon Health & Science University)+ 1 AuthorsAaron B. Caughey57
Estimated H-index: 57
(Oregon Health & Science University)
Source Cite
Published on Mar 1, 2019in Nature 41.58
Eunju Kang13
Estimated H-index: 13
(Oregon National Primate Research Center),
Jun Wu28
Estimated H-index: 28
(Salk Institute for Biological Studies)
+ 27 AuthorsYeonmi Lee6
Estimated H-index: 6
(Oregon National Primate Research Center)
Change history In this Letter, there are several errors regarding the assignments of mtDNA haplotypes for a subset of egg donors from our study. These errors have not been corrected online.
Source Cite
Published on Sep 11, 2018
Hong Ma27
Estimated H-index: 27
,
Nuria Marti-Gutierrez1
Estimated H-index: 1
+ 27 AuthorsRiffat Ahmed10
Estimated H-index: 10
Source Cite
Published on Aug 1, 2017in Nature 41.58
Hong Ma27
Estimated H-index: 27
(Oregon National Primate Research Center),
Nuria Marti-Gutierrez1
Estimated H-index: 1
(Oregon Health & Science University)
+ 28 AuthorsRiffat Ahmed10
Estimated H-index: 10
(Oregon Health & Science University)
CRISPR–Cas9 genome editing is used to induce a DNA repair response and correct a disease-causing heterozygous mutation in human embryos with reduced mosaicism and preferential repair using the wild-type copy of the gene.
259 Citations Source Cite
Published on May 1, 2017in Obstetrics & Gynecology 4.98
Emily K. Clennon , Aaron B. Caughey57
Estimated H-index: 57
+ 2 AuthorsPaula Amato21
Estimated H-index: 21
Source Cite
Published on May 1, 2017in Obstetrics & Gynecology 4.98
Emily K. Clennon , Aaron B. Caughey57
Estimated H-index: 57
+ 2 AuthorsPaula Amato21
Estimated H-index: 21
Source Cite
Published on Jan 1, 2017
Paula Amato21
Estimated H-index: 21
(Oregon Health & Science University)
The general purpose of ovarian reserve testing is to assess the quantity and quality of the remaining oocytes in an attempt to predict reproductive potential. Ovarian reserve testing should be performed in women older than 35 years who have not conceived after 6 months of attempting pregnancy (or women less than 35 who have not conceived after 1 year) and women at higher risk of diminished ovarian reserve, such as those with a history of cancer or other medical condition treated with gonadotoxic...
Source Cite
Published on Jan 1, 2017in Cell Stem Cell 23.29
Hong Ma27
Estimated H-index: 27
(Oregon Health & Science University),
Ryan C. O’Neil4
Estimated H-index: 4
(University of California, San Diego)
+ 23 AuthorsYeonmi Lee6
Estimated H-index: 6
(Oregon Health & Science University)
Summary Oocyte defects lie at the heart of some forms of infertility and could potentially be addressed therapeutically by alternative routes for oocyte formation. Here, we describe the generation of functional human oocytes following nuclear transfer of first polar body (PB1) genomes from metaphase II (MII) oocytes into enucleated donor MII cytoplasm (PBNT). The reconstructed oocytes supported the formation of de novo meiotic spindles and, after fertilization with sperm, meiosis completion and ...
21 Citations Source Cite
Published on Dec 1, 2016in Nature 41.58
Eunju Kang13
Estimated H-index: 13
(University of Ulsan),
Jun Wu28
Estimated H-index: 28
(Salk Institute for Biological Studies)
+ 27 AuthorsYeonmi Lee6
Estimated H-index: 6
(Oregon Health & Science University)
Analysis of mitochondrial replacement therapy shows, even with efficient mutant mitochondrial DNA replacement and maintenance in embryonic stem cells, a gradual loss of donor mitochondrial DNA in some lines owing to a polymorphism in the D-loop, potentially causing preferential replication of specific mitochondrial DNA haplotypes.
70 Citations Source Cite
12345